Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Coronary Artery Disease
Interventions
DRUG

ticagrelor

ticagrelor 90 mg BID for 90 days

DRUG

Placebo

Placebo 1 pill BID for 90 days

Trial Locations (1)

Unknown

Vancouver General Hospital, Vancouver

All Listed Sponsors
collaborator

University of British Columbia

OTHER

lead

Cardiology Research UBC

OTHER

NCT01373411 - Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery | Biotech Hunter | Biotech Hunter